Nineteen isolants of infectious bronchitis virus (IBV), including most of the recently reported new isolants, were adapted to chick kidney cell cultures. After plaque purification and the preparation of antiserums against purified strains, antigen interrelatedness was evaluated with cross-neutralization tests by the plaque-reduction technique. The results indicated that there are 7 serotypes current in the United States and that the Australian "T" strain is distinct from each of these. Antigenic variants occurred within some of these serotypes.
INTRODUCTION
Because new or variant infectious bronchitis virus (IBV) serotypes have been reported more frequently in recent years, it has become increasingly clear that methods of serotyping this virus must be improved. The serum-neutralization (SN) test has been used in nearly all previous reports dealing with serotyping of IBV. Generally, those studies have used strains whose purity was uncertain because the limit dilution technique was used for purification, and virus infectivity was assayed in the embryo. The limitations of such techniques are well recognized. Among these limitations are the subjective nature of interpretation of the deforming or dwarfing effects of the virus on the chick embryo and the confusion that results when mixed virus populations are encountered (4) .
Both of these limitations are avoided by SN tests with plaquepurified virus assayed in cell culture by the plaque-reduction technique. Although aspects of this system for the Beaudette strain of IBV have been discussed by Cunningham and Spring (5) and by Lukert (11) , the value of the test could not be fully realized until 231 all of the proposed serotypes and a representative sample of field isolates could be adapted to cell culture, plaque-purified, and crosscompared in cell culture by using antiserums against the purified virus. This report contains the results of efforts to fully use the plaque-reduction technique for serotyping IBV.
MATERIALS AND METHODS
Virus. The virus strains used either were received at this laboratory in chicken embryo allantoic fluid (AF) or were isolated in chicken embryos from chicken tracheas at this laboratory. They are identified in Table 1 . The plaque-purified virus lines (see below) were all shown to be nonhemagglutinating and were not neutralized by antiserum against CELO, a virus likely to contaminate cell cultures. Additionally, all of these lines were ethersensitive and negative for Mycoplasma sp. by cultural methods.
Cell culture. The cell monolayers were primary cultures of trypsin-dispersed 2-to-3-week-old chick kidney (CK). Cultures were grown on plastic trays with 6 dishes (10 X 35 mm) per tray or in plastic cell-culture flasks (250 ml). The seeding medium was Eagle's basal medium in Earle's balanced salt solution with 7% fetal calf serum. The maintenance medium (MM) was 199 without serum. The cell monolayers were confluent and ready to use 72 hours after seeding. At that time, they were washed in Earle's or Hanks' balanced salt solution and inoculated. If cultures were not inoculated at 72 hours, they could be held in MM up to 5 days after seeding. All incubation was at 37 C in an atmosphere of 0.5% CO2.
For the plaque assay, cell cultures were overlaid without rins-ing after a 1-hour attachment period with 2 ml per dish of 199 containing 1% agar. After 48 hours' incubation, 1 ml of neutral red (NR) solution (1/5000 NR in balanced salt solution) was added by flooding the agar overlay. In 2-3 hours, the fluid was removed by aspiration, the NR having diffused into the original agar overlay. Plaque counts were then made. When plaques were to be harvested, the inoculum was aspirated after the attachment period, the cell sheet rinsed with MM, and the initial agar overlay applied as above. After a 48-hour incubation period, 1 ml of NR agar was added (1/5000 NR and 1%o agar in balanced saline).
Passage and cloning. Washed cell cultures were inoculated initially with 0.1 ml of undiluted virus-laden AF. After a 1-hour attachment period at 37 C, MM was added and incubation continued. Observations were made daily for cytopathic effect (CPE). The maintenance fluid was harvested after 48 hours and passed or frozen for later passage, depending on the availability of cultures. Once CPE was observed with a particular strain of IBV, the passage interval was reduced to 24-30 hours.
When the strain appeared to be adapted to produce CPE readily in CK cells, the virus was plaqued for purification. Isolated plaques were picked for passage by cutting a small plug from the agar over the plaque and then washing the plug in 0.2 ml 199 medium. This fluid was used for the next passage in cell culture. Two plaque-purification passages were made. Virus seed and working stocks were prepared by inoculating the plaque-purified lines in CK cells in flasks. The maintenance medium from these flasks was centrifuged to remove cell debris and stored frozen (-60 C) in 1-ml portions.
Source of chickens. The source was a closed unvaccinated flock of White Plymouth Rock chickens hatched and raised in filteredair positive-pressure housing (7). These production flocks were proved free of IBV, Newcastle disease, Mycoplasma gallisepticum, and M. synoviae. The chicks that served as a source of kidneys for the cell cultures or were used to prepare antiserum were hatched from eggs from the source flock in filtered-air positive-pressure Horsfall-Bauer units and maintained in isolation (6).
Antiserum. The antiserums were derived from 6-week-old convalescent chickens. They were prepared by inoculating 5 threeweek-old chickens intratracheally with 0.2 ml of undiluted plaquepurified virus in cell-culture fluids. The birds were observed for 233, 
RESULTS
The passage of IBV strains in CK produced CPE in all cases by the sixth serial passage. The CPE was characterized by foci of refractile round cells and occasional syncytia. The affected cells became detached from the monolayer and tended to aggregate in clumps that floated free in the nutrient medium. These clumps gave a characteristic appearance that could be observed in culture fluid even when isolated foci of CPE were initially overlooked. Table 2 shows that including calf serum as a nutrient in the agar overlay lowered the total plaque count. These nonspecific (non-antibody) (12) inhibitors of IBV cause a similar lowering of plaque count if the monolayer is not washed to remove traces of nutrient serum in the growth medium before inoculation. Nonspecific inhibitors are also present in normal chicken serum and will also reduce plaque count. Table 3 shows a drop of about 50% in plaque count even in serum heated to 56 C for 30 minutes and diluted 1:10. For this reason, normal serum controls must be run with each test to establish baseline counts against which plaque reduction of the test serum can be measured.
When plaque-purified virus was tested by cross-serum neutralization against mono-typic serum derived from plaque-purified virus, 8 strains (Table 4) exhibited distinct antigenic differences. The one-way cross reaction occurred between JMK serum and SE 17 virus. The difference is three 2-fold dilutions between the homo- (Table 5 ). Even so, these apparently antigenically related strains produced plaques of distinctly different morphology. SE 17 virus plaques were small, averaging 1 mm in diameter, cloudy, and irregular at 72 hours. MD 27 virus plaques averaged 2.5 mm in diameter and were clearer and more regular at their periphery. No such differences in plaque morphology were observed among the viruses related to JMK (Table 6 ). These 4 strains appear to have closely related antigenic determinants, with the interrelationships all above the 70 % level. Table 7 Gray  JMK  80A  40  80  80  Md 20  320  320  320  160  Holte  40  20  40  40  Gray  40  40  80  80 AReciprocal of the highest serum dilution that neutralizes 90% of virus. Serum  41  29  13121  10285   41  80  20  29  80  160  80  80  13121  10  160  10285 10 20
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in Table 8 Each strain of IBV listed in Table 1 was tested by reciprocal plaque-reduction serum neutralization against each of the other strains; and except as reported in Tables 4-8 , the heterologous serum titers were 1:10 or less, and the maximum relatedness ratio was 0.06. A tentative proposed arrangement of these IBV strains by serotype is as follows: 
DISCUSSION
The problems with nonspecific inhibitors of IBV present in animal serums have been dealt with in depth by Lukert (12). Such inhibitors may account for the failure of earlier efforts to apply cell-culture techniques to IBV research and must be considered in dealing with IBV in cell-culture systems or in the chicken embryo. Neutralization tests that use undiluted serum for assays of IBV antibody are likely to be invalid even if the serum is heat-inactivated. Because the level of inhibitors varies from bird to bird, the Serum  46  88  13721  333  99L   46  320  10  80  40  18288  40  160  10  40  40  13721  80  320  20  Clarke 333  20  40  NT  80  160  99L  NTB  NT  NT  40  80 AReciprocal of the highest serum dilution that causes a 90% reduction in plaque count. Those points for which no value is recorded are less than 1:10. BNT = not tested.
inclusion of a normal serum control in the neutralization test is only a partial answer to control of this variable in the IBV system, particularly in undiluted serum, where the effect of the inhibitors is greatest. The proven methods of virus research that have been developed over the past 20 years and that have been so fruitful when applied to other animal viruses are now becoming increasingly applicable to research on IBV. Among such methods is the use of cell culture for cloning and enumeration of virus populations. This technique brings a higher order of certainty to IBV research than was possible with the use of chick embryos.
Although certain highly egg-adapted laboratory strains of IBV were readily propagated in cell culture, full use of the cell-culture technique was impossible because the strains isolated from natural outbreaks did not produce a cytopathic effect. All strains of IBV investigated at this laboratory have eventually exhibited a CPE and have subsequently been plaqued and compared serologically. With some, however, notably Clarke 333, repeated attempts were required. For example, Clarke 333 did not produce CPE until the third blind-passage series was started from allantoic fluid.
The results of these serological comparisons indicate that there are 7 distinct domestic serotypes of IBV and at least one foreign serotype. In addition, some strains, such as the Florida 18288 strain, must be considered variant strains of a serotype on the basis of one-way crossing in reciprocal plaque-reduction tests. Now that the serologic relatedness among many of the strains is established, cross-immunity studies are needed to determine the importance of any effects that these serotypes and variants have on vaccine efficacy. At the level of the tracheal epithelium, factors other than circulating antibodies may be responsible for its protection against IBV infection, and assay of circulating antibody may afford only an indirect indication of protection. However, at the level of the reproductive tract, circulating antibodies are likely the chief mechanism of defense.
A most neglected area of investigation for IBV has been the geographic distribution and spread of the various serotypes. Epidemiological studies with these more precise serologic methods would be useful to determine their distribution.
Now that more precise methods of IBV assay are available, we hope there can be progress toward a general agreement on standardization of test procedures and of criteria interpretation when pursuing any of these objectives.
